Skip to content

Drug interactions

Eluxadoline + Valsartan

Severity: Minor

Eluxadoline and Valsartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eluxadoline is an OATP1B1 substrate, and OATP1B1 inhibitors raise its exposure. Valsartan is a weak OATP1B1 substrate and not a well-established inhibitor, so a meaningful interaction is uncertain.

What this interaction means in plain words

Eluxadoline and Valsartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eluxadoline belongs to Gastrointestinal Tract; Valsartan belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible competition at OATP1B1 uptake; not well established.

What to do

No dose change required; monitor for eluxadoline adverse effects such as constipation and abdominal pain.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eluxadoline and Valsartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eluxadoline with Valsartan?

MediHelp rates the interaction as minor. Eluxadoline and Valsartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eluxadoline is an OATP1B1 substrate, and OATP1B1 inhibitors raise its exposure. Valsartan is a weak OATP1B1 substrate and not a well-established inhibitor, so a meaningful interaction is uncertain.

How serious is the interaction between Eluxadoline and Valsartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change required; monitor for eluxadoline adverse effects such as constipation and abdominal pain.

What other medicines interact with Valsartan?

MediHelp also lists interactions of Valsartan with, for example, Aliskiren, Sparsentan, Aldesleukin. The full list is on the Valsartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in